SE511237C2 - Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor - Google Patents

Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor

Info

Publication number
SE511237C2
SE511237C2 SE9704693A SE9704693A SE511237C2 SE 511237 C2 SE511237 C2 SE 511237C2 SE 9704693 A SE9704693 A SE 9704693A SE 9704693 A SE9704693 A SE 9704693A SE 511237 C2 SE511237 C2 SE 511237C2
Authority
SE
Sweden
Prior art keywords
astaxanthin
human
mothers
mastitis
type
Prior art date
Application number
SE9704693A
Other languages
English (en)
Swedish (sv)
Other versions
SE9704693L (sv
SE9704693D0 (sv
Inventor
Aake Lignell
Johan Inborr
Original Assignee
Astacarotene Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astacarotene Ab filed Critical Astacarotene Ab
Priority to SE9704693A priority Critical patent/SE511237C2/sv
Publication of SE9704693D0 publication Critical patent/SE9704693D0/xx
Priority to AU18972/99A priority patent/AU743198B2/en
Priority to DE69814467T priority patent/DE69814467D1/de
Priority to NZ504801A priority patent/NZ504801A/en
Priority to AT98963702T priority patent/ATE239457T1/de
Priority to JP2000538684A priority patent/JP2002508318A/ja
Priority to EP98963702A priority patent/EP1049460B1/de
Priority to PCT/SE1998/002279 priority patent/WO1999030701A1/en
Priority to CA002314170A priority patent/CA2314170C/en
Priority to US09/589,594 priority patent/US6335015B1/en
Priority to ARP980106418A priority patent/AR017877A1/es
Publication of SE9704693L publication Critical patent/SE9704693L/
Publication of SE511237C2 publication Critical patent/SE511237C2/sv
Priority to NO20003042A priority patent/NO327301B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Pregnancy & Childbirth (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
SE9704693A 1997-12-16 1997-12-16 Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor SE511237C2 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE9704693A SE511237C2 (sv) 1997-12-16 1997-12-16 Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor
US09/589,594 US6335015B1 (en) 1997-12-16 1998-12-10 Method of the prophylactic treatment of mastitis
EP98963702A EP1049460B1 (de) 1997-12-16 1998-12-10 Verfahren zur prophylaktischen behandlung von mastitis
DE69814467T DE69814467D1 (de) 1997-12-16 1998-12-10 Verfahren zur prophylaktischen behandlung von mastitis
NZ504801A NZ504801A (en) 1997-12-16 1998-12-10 A medicament containing one type of xanthophylis for the prophylactic treatment of mastitis
AT98963702T ATE239457T1 (de) 1997-12-16 1998-12-10 Verfahren zur prophylaktischen behandlung von mastitis
JP2000538684A JP2002508318A (ja) 1997-12-16 1998-12-10 乳腺炎の予防処置法
AU18972/99A AU743198B2 (en) 1997-12-16 1998-12-10 Method of the prophylactic treatment of mastitis
PCT/SE1998/002279 WO1999030701A1 (en) 1997-12-16 1998-12-10 Method of the prophylactic treatment of mastitis
CA002314170A CA2314170C (en) 1997-12-16 1998-12-10 Method of the prophylactic treatment of mastitis
ARP980106418A AR017877A1 (es) 1997-12-16 1998-12-16 Metodo para el tratamiento profilactico de la mastitis y su uso de al menos un tipo de xantofila para preparar medicamentos de aplicacion en dicho metodo
NO20003042A NO327301B1 (no) 1997-12-16 2000-06-14 Anvendelse av astaxanthin for fremstilling av et medikament til behandling av mastitt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704693A SE511237C2 (sv) 1997-12-16 1997-12-16 Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor

Publications (3)

Publication Number Publication Date
SE9704693D0 SE9704693D0 (sv) 1997-12-16
SE9704693L SE9704693L (sv) 1999-06-17
SE511237C2 true SE511237C2 (sv) 1999-08-30

Family

ID=20409414

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9704693A SE511237C2 (sv) 1997-12-16 1997-12-16 Användning av åtminstone en typ av xantofyller för framställning av ett humant eller verinärmedicinskt läkemedel för profylaktisk behandling av mastit hos däggdjursmammor

Country Status (12)

Country Link
US (1) US6335015B1 (de)
EP (1) EP1049460B1 (de)
JP (1) JP2002508318A (de)
AR (1) AR017877A1 (de)
AT (1) ATE239457T1 (de)
AU (1) AU743198B2 (de)
CA (1) CA2314170C (de)
DE (1) DE69814467D1 (de)
NO (1) NO327301B1 (de)
NZ (1) NZ504801A (de)
SE (1) SE511237C2 (de)
WO (1) WO1999030701A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903336D0 (sv) * 1999-09-17 1999-09-17 Astacarotene Ab DNA construct and its use
SE9903619D0 (sv) * 1999-10-07 1999-10-07 Astacarotene Ab Use and method of treatment
US7723327B2 (en) 2002-07-29 2010-05-25 Cardax Pharmaceuticals, Inc. Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver disease
US7521584B2 (en) 2002-07-29 2009-04-21 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of disease
MXPA05001202A (es) 2002-07-29 2005-11-23 Hawaii Biotech Inc Analogos carotenoides estructurales para la inhibicion y mejora de la enfermedad.
US20050143475A1 (en) * 2002-07-29 2005-06-30 Lockwood Samuel F. Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injury
US7763649B2 (en) 2002-07-29 2010-07-27 Cardax Pharmaceuticals, Inc. Carotenoid analogs or derivatives for controlling connexin 43 expression
US20050148517A1 (en) * 2002-07-29 2005-07-07 Lockwood Samuel F. Carotenoid ether analogs or derivatives for controlling connexin 43 expression
US7320997B2 (en) 2002-07-29 2008-01-22 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of disease
US20050059635A1 (en) * 2002-07-29 2005-03-17 Lockwood Samuel Fournier Carotenoid ester analogs or derivatives for controlling C-reactive protein levels
US7345091B2 (en) 2002-07-29 2008-03-18 Cardax Pharmaceuticals, Inc. Carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US7375133B2 (en) * 2002-07-29 2008-05-20 Cardax Pharmaceuticals, Inc. Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
US20060058269A1 (en) * 2004-04-14 2006-03-16 Lockwood Samuel F Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
WO2005102356A1 (en) * 2004-04-14 2005-11-03 Hawaii Biotech, Inc. Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
HUE041585T2 (hu) 2004-09-28 2019-05-28 Avivagen Inc Kompozíciók és eljárások súlygyarapodás és táplálék konverzió elõsegítésére
US20060088905A1 (en) * 2004-10-01 2006-04-27 Lockwood Samuel F Methods for the synthesis of zeazanthin
PL2214656T3 (pl) 2007-10-26 2019-06-28 Avivagen Inc. Kompozycje i sposoby wzmacniania odpowiedzi immunologicznej
WO2010124392A1 (en) * 2009-04-30 2010-11-04 Chemaphor Inc. Methods, compositions, and kits for the treatment of inflammatory conditions
CA2771204C (en) 2009-04-30 2017-09-19 Chemaphor Inc. Methods and compositions for improving the health of animals
EP4106547A4 (de) * 2020-02-18 2024-03-13 Avivagen Inc. Supplementierte tierfuttermittel für säugetiere

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2619491B2 (ja) 1988-08-11 1997-06-11 サントリー株式会社 アスタキサンチン含有組成物
US5886053A (en) * 1995-02-03 1999-03-23 Basf Aktiengesellschaft Use of carotenoids for producing drugs for the treatment of dermatoses
JPH09124470A (ja) * 1995-10-26 1997-05-13 Suntory Ltd 抗ストレス組成物
SE506191C2 (sv) * 1996-03-27 1997-11-17 Astacarotene Ab Medel och sätt för att öka produktionen av/hos däggdjur

Also Published As

Publication number Publication date
ATE239457T1 (de) 2003-05-15
AU1897299A (en) 1999-07-05
EP1049460A1 (de) 2000-11-08
DE69814467D1 (de) 2003-06-12
SE9704693L (sv) 1999-06-17
CA2314170C (en) 2008-01-29
CA2314170A1 (en) 1999-06-24
AU743198B2 (en) 2002-01-24
EP1049460B1 (de) 2003-05-07
NO20003042L (no) 2000-06-14
US6335015B1 (en) 2002-01-01
WO1999030701A1 (en) 1999-06-24
JP2002508318A (ja) 2002-03-19
AR017877A1 (es) 2001-10-24
SE9704693D0 (sv) 1997-12-16
NZ504801A (en) 2002-05-31
NO20003042D0 (no) 2000-06-14
NO327301B1 (no) 2009-06-02

Similar Documents

Publication Publication Date Title
EP0559425B1 (de) Verwendung von Proteinen der Transferrin/Lactoferrin-Familie zur Stimulation des Immunsystems
AU743198B2 (en) Method of the prophylactic treatment of mastitis
US11806375B2 (en) Nutritional support for animals via administration of an algal derived supplement
BG62757B1 (bg) Фармацевтични състави на основата на растителни етерични масла за хуманната и ветеринарната медицина
SE512531C2 (sv) Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk förbättring av muskelfunktionsdurationen hos däggdjur och/eller behandling av muskelstörningar eller - sjukdomar hos däggdjur
EP1655292B1 (de) Präventive bzw. therapeutische zusammensetzung gegen virale infektionskrankheiten
Bazekin et al. The Effect of New Immunostimulants of Tissue and Plant Origin on the Morphological Characteristics of the Immune System's Central Organs and the Dynamics of Serum Immunoglobulins
US11612629B2 (en) Pharmaceutical composition for preventing or treating muscle diseases, containing ginseng berry extract as active ingredient
KR101260250B1 (ko) 패모 추출물을 포함하는 항 호흡기 바이러스용 조성물
US6475547B1 (en) Immunoglobulin-rich milk, production and use thereof
SE513186C2 (sv) Sätt att öka produktionen av och förbättra kvaliteten hos sperma med användning av xantofyller
JP2009269832A (ja) カルシトニン遺伝子関連ペプチド及びインスリン様成長因子−１の産生促進組成物
WO2002038146A1 (en) Mucosal immunomodulator and use thereof
SE524337C2 (sv) Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär
JPS5925769B2 (ja) 動物薬組成物ならびにその製法
JP6280356B2 (ja) 育毛・発毛促進用経口剤
Semba The vitamin A and mortality paradigm: past, present, and future
KR101728094B1 (ko) 개머루덩굴 추출물 또는 이의 분획물을 유효성분으로 포함하는 바이러스성 질환 및 암의 예방 또는 치료용 약학적 조성물
KR20190085761A (ko) 맥주효모를　유효성분으로 하는　면역증진　및　항염효과 증진용　복합추출 조성물
CN106474163B (zh) 牛樟芝子实体萃取组合物的用途
JP2024061593A (ja) インターロイキン－１２産生促進剤
JP2023119096A (ja) 間葉系細胞活性化剤、創傷治療剤、間葉系細胞活性化用経口組成物及び創傷治療用経口組成物
RU1669100C (ru) Способ выращивани птиц
Akubueze et al. JOURNAL OF VETERINARY AND APPLIED SCIENCES
JP2008038011A (ja) 高純度リン脂質の製造法

Legal Events

Date Code Title Description
NUG Patent has lapsed